Nihon Medi Physics   Report issue

For profit Phase 1 Phase 2
Founded: Koto-ku United States (1973)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2009
NCT01502670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Nihon Medi-Physics Co., Ltd. | NIHON MEDI-PHYSICS CO.,LTD.